Umfassende Service-Einschränkungen im Bereich Ausleihe ab 17. März!
ISO-690 (author-date, English)

MILANOVIĆ, Dušan, STICHT, Carsten, RÖHRICH, Manuel, MAIER, Patrick, GROSU, Anca-Ligia und HERSKIND, Carsten, 2025. Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo. Freiburg: Universität.

Elsevier - Harvard (with titles)

Milanović, D., Sticht, C., Röhrich, M., Maier, P., Grosu, A.-L., Herskind, C., 2025. Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo. Universität, Freiburg. https://doi.org/10.18632/oncotarget.4727

American Psychological Association 7th edition

Milanović, D., Sticht, C., Röhrich, M., Maier, P., Grosu, A.-L., & Herskind, C. (ca. 2025). Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo [Cd]. Universität. https://doi.org/10.18632/oncotarget.4727

Springer - Basic (author-date)

Milanović D, Sticht C, Röhrich M, Maier P, Grosu A-L, Herskind C (2025) Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo. Universität, Freiburg

Juristische Zitierweise (Stüber) (Deutsch)

Milanović, Dušan/ Sticht, Carsten/ Röhrich, Manuel/ Maier, Patrick/ Grosu, Anca-Ligia/ Herskind, Carsten, Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo, Freiburg 2025.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.